HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

3-methyladenosine

structure in first source

Also Known As:

Adenosine, N,6-didehydro-3,6-dihydro-3-methyl-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 651
      - Purine Nucleosides: 360
        Adenosine: 12431
        3-methyladenosine: 1
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
  - Purine Nucleosides: 360
    - Adenosine: 12431
      - 3-methyladenosine: 1
  - Ribonucleosides: 49
    - Adenosine: 12431
      - 3-methyladenosine: 1

Experts

1.	Cheng, Y: 1 article (02/2012)
2.	Liu, D: 1 article (02/2012)
3.	Patel, R: 1 article (02/2012)
4.	Qin, Z-H: 1 article (02/2012)
5.	Ren, X: 1 article (02/2012)
6.	Shih, I-M: 1 article (02/2012)
7.	Wu, H: 1 article (02/2012)
8.	Yang, J-M: 1 article (02/2012)
9.	Yap, K L: 1 article (02/2012)
10.	Zhang, L: 1 article (02/2012)

Related Diseases

1.	Neoplasms (Cancer) 02/23/2012 - "Treatment with 3-methyladenosine, chloroquine or beclin 1 and Atg5-targeted siRNA also enhanced the sensitivity of SKOV3, A2780 and OVCAR3 cells to cisplatin, indicating that suppression of autophagy indeed renders tumor cells more sensitive to cisplatin. "

Related Drugs and Biologics

1.	Small Interfering RNA (siRNA)
2.	Cisplatin (Platino)
3.	Chloroquine (Aralen)
4.	Beclin-1